Silexion Therapeutics Corp
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 30 →InsidersNo open-market buys. 1 insider sold $31,032 in 1 sale, with no 10b5-1 plan named.→Financing →PeersClosest companies: AKTX, INDP, ERAS→
From the filings
Figures
- Net income
- −$14.0Mlast 12 months
- Operating cash flow
- −$12.4Mlast 12 months
- Cash and equivalents
- $2.2Mat the last balance sheet
- Shares outstanding
- 1.2M shareson issue